To tackle a backlog in toxicity testing, US federal scientists are modernizing programs with high-throughput assays and AI.
to evaluate the toxicity or effectiveness of substances of interest, including potential therapeutic agents. For example, researchers will measure cell death to determine a drug’s anticancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback